New Pill Can Double Life Expectancy in Pancreatic Cancer Patients, Study Finds (opens in new tab)

In a clinical trial, researchers found that a drug called Daraxonrasib doubled the survival time in patients diagnosed with pancreatic cancer\. This is significant as more than half of people with pancreatic cancer die within three months of diagnosis\. Amid this, a report projected a shortfall of 100 million cancer care workers by 2050\. \#cancer \#pancreatic \#health \#wion About Channel: WION The World is One News examines global issues with in-depth analysis\. We provide much more than th...